comparemela.com

Latest Breaking News On - Relay therapeutics - Page 9 : comparemela.com

Cantor sees strong year ahead for oncology M&A (NASDAQ:KURA)

Cantor sees strong year ahead for oncology M&A (NASDAQ:KURA)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Cantor-fitzgerald
Bristol-myers
Novo-nordisk
Big-pharma
Day-one
Legend-biotech
Relay-therapeutics
Revolution-medicines
Springworks-therapeutics

Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Sold by Profund Advisors LLC

Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Sold by Profund Advisors LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada
Leerink-partnrs
Stifel-nicolaus
Relay-therapeutics-inc
Vontobel-holding-ltd
Nasdaq
Russell-investments-group-ltd
Profund-advisors
Great-west-life-assurance-co
Royal-bank
Life-insurance-co
Exchange-commission

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the ten analysts that are covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to […]

Stifel-nicolaus
Morgan-stanley
Relay-therapeutics-inc
Norges-bank
Pricet-rowe-associates-inc
Nasdaq
Relay-therapeutics
Get-free-report
State-street-corp
Street-corp
Get-free
Relay-therapeutics-daily

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $24.61 Consensus Target Price from Analysts

Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten brokerages that are presently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy […]

Ohio
United-states
Stifel-nicolaus
Barclays-plc
Voloridge-investment-management
Relay-therapeutics-inc
Vanguard-group-inc
Nasdaq
Relay-therapeutics
Get-free-report
Marketbeat-ratings
Employees-retirement-system

Relay Therapeutics Full Year 2023 Earnings: Beats Expectations

Relay Therapeutics ( NASDAQ:RLAY ) Full Year 2023 Results Key Financial Results Revenue: US$25.5m (up by US$24.2m from.

Therapeutics-revenues
Earnings-beat
Relay-therapeutics
Earnings-per-share
Y
Revenue-history

vimarsana © 2020. All Rights Reserved.